January 14, 2022 – Recently, life sciences-focused search firm Slone Partners placed Brian Hogan as chief financial officer of InterVenn Biosciences. “Brian Hogan is an extremely smart and innovative financial executive with a track record of success throughout his career in the life sciences,” said Tara Kochis-Stach, president of Slone Partners. “He brings energy, passion and vision to the InterVenn leadership team as the company expands its footprint in the liquid biopsy, diagnostics and healthcare space.” “I am delighted to welcome Brian to InterVenn as our CFO,” said Aldo Carrascoso, CEO of InterVenn. “The expansion of InterVenn’s executive leadership team with this critical new hire is a significant step forward toward our ability to take the company to the next level. With his extensive experience in the life sciences industry, Brian’s leadership within the financial function will be a driving force to scale our organization and help accelerate the growth of our innovative pipeline of liquid biopsy products and clinical solutions.”
“We are happy to continue to add talent at InterVenn in partnership with Slone Partners,” said Erwin Estigarribia, COO at InterVenn. “They have what we believe is a critical understanding of our values and are able to match candidates to our needs where other recruiting organizations have struggled.”
Mr. Hogan brings more than 20 years of finance and leadership experience in public and private companies to InterVenn. Prior to joining the company, he was CFO at Clear Labs. His previous roles also included: senior vice president of global finance and accounting at Portola, CFO at Adicet Bio and VP of finance at Genomic Health.
In his new role at InterVenn, Mr. Hogan will have responsibility for all aspects of finance and investor relations as the company accelerates its growth strategy to scale the company’s capabilities, operations and partnerships.
Based in South San Francisco, CA, InterVenn Biosciences utilizes a proprietary glycoproteomic biomarker interrogation platform using AI and mass spectrometry for Next-Gen precision medicine. The company is working to find new solutions in ovarian, pancreatic, liver, prostate and kidney cancer, together with applications from the Vista suite of solutions for treatment and monitoring, immune profiling, patient stratification and disease progression.
Slone Partners also assisted in the recruitment of Stephana Patton as chief legal officer at InterVenn Biosciences. “Dr. Patton is an extraordinarily talented and experienced legal mind with a track record of success wherever she’s been,” said Ms. Kochis-Stach. “She brings terrific insight and intellect to the InterVenn executive team.”
Slone Partners Recruits CEO for Mesa Biotech
The race is on to find a vaccine for COVID-19 – and along with it the pace is picking up to find top leadership talent at many of the nation’s leading life sciences, medical diagnostics and biotech companies. Here’s one of the latest searches just successfully completed.
In 2020, Slone placed John Leite as chief business officer at InterVenn. “John Leite is an experienced and highly accomplished business development and marketing specialist in the biotechnology and diagnostics sectors,” Ms. Tara Kochis-Stach. In his role with InterVenn Biosciences, Mr. Leite directs all business operations for the company as part of its global leadership team.
Slone Partners is a nationally recognized senior-level recruitment provider that specializes in delivering executive, management and leadership talent for the diagnostic, biopharmaceutical, healthcare information technology and laboratory testing industries. The firm has offices in Boston, New York, Washington, D.C. and San Francisco. Recently, Slone Partners was included among Hunt Scanlon Media’s “Top 50 Healthcare & Life Sciences Search Firms.”
Ms. Kochis-Stach joined the firm in 2004, bringing over a decade of healthcare experience. Her past sales career with industry leaders such as VERSYSS, American Medical Laboratories and Quest Diagnostics covered a wide variety of healthcare segments, including information technology, medical records, and the diagnostic and laboratory testing industry. Prior to healthcare, Ms. Kochis-Stach recruited executive and management talent in the banking and finance sector.
Contributed by Scott A. Scanlon, Editor-in-Chief; Dale M. Zupsansky, Managing Editor; and Stephen Sawicki, Managing Editor – Hunt Scanlon Media